NASDAQ: TVGN

Tevogen Bio Holdings Inc.

Healthcare | Biotechnology

No licensed closing price on file for TVGN. This page shows the company’s SEC filings and filed figures, without a price or any ratio that depends on one.

Tevogen Bio Holdings Inc. (NASDAQ: TVGN) is a biotechnology company. Figures from SEC EDGAR; updated 2026-10-20 17:09 UTC.

What Tevogen Bio Holdings Inc. does

The company is a clinical-stage biotechnology firm developing off-the-shelf T cell therapies using its ExacTcell technology platform, which harnesses CD8+ cytotoxic T lymphocytes to treat infectious diseases, cancers, and other disorders. ExacTcell is a set of processes designed to develop, enrich, and expand naturally occurring T cell therapies that target multiple distinct antigens, unlike genetically engineered approaches.

Summarized from Tevogen Bio Holdings Inc.’s SEC filings · AI-generated analysis. Not investment advice. May contain errors. · Read the filing ↗

Key facts

Charts

Charts are in the appInteractive charts for TVGN are available in Oxford Ledge.
Open TVGN in Oxford Ledge →

SEC Filings

SEC EDGAR ↗

Recent Insider Activity (last 90 days)

Source: SEC EDGAR · Filed 2026-09-16

2026-09-16Chief Financial OfficerAward750,000—
2026-09-16Chief Executive OfficerAward8,000,000—
2026-09-15DirectorAward75,000—

Top Institutional Holders (latest 13F)

Source: SEC EDGAR · As of 2026-Q2

FourWorld Capital Management LLC1,450,000$8.21M0.0%
TENOR CAPITAL MANAGEMENT Co., L.P.125,000$4.24M0.0%
Q Global Advisors, LLC132,146$4.00M0.0%

View QoQ ownership changes →Full institutional ownership →

Recent 8-K Events (parsed from SEC filings)All events →

Source: SEC EDGAR 8-K filings · Interpretation: Oxford Ledge parser · Confidence-filtered ≥ 0.50

2026-09-16Exec ChangeDeparture of directors or certain officers; election of directors; appointment of certain officers; compensatory arrangements of certain officersEstimatedSEC 8-K →
2024-05-02AuditorChanges in registrant's certifying accountantKPMG LLPEstimatedSEC 8-K →
2023-06-07Exec ChangeDeparture of directors or certain officers; election of directors; appointment of certain officers; compensatory arrangements of certain officersEstimatedSEC 8-K →

Company news

View all →

Tevogen Bio Announces 2026 Annual Meeting of Stockholders
globenewswire.com2026-07-13
Fewer than five qualifying stories — full tape in the platform →

For you

Charts, 10-year financials, peer comparison, screening and portfolio tracking for TVGN and 5,000+ tickers.

Create a free account — keep TVGN

For your agent

GET /api/data?ticker=TVGN

This page as JSON via rel="alternate" · REST API docs · MCP server (60 tools) · llms.txt